Mutational spectrum and DNA-based prenatal diagnosis in carnitine-acylcarnitine translocase deficiency

被引:23
|
作者
Costa, C
Costa, JM
Slama, A
Boutron, A
Vequaud, C
Legrand, A
Brivet, M
机构
[1] AP HP Hop Bicetre, Lab Biochim 1, F-94270 Le Kremlin Bicetre, France
[2] AP HP Hop H Mondor, Biochim Lab, Creteil, France
[3] Hop Amer Paris, Mol Biol Lab, Paris, France
关键词
carnitine-acylcarnitine translocase; carnitine-acylcarnitine carrier; long-chain fatty acid oxidation; DNA-based prenatal diagnosis;
D O I
10.1016/S1096-7192(02)00205-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Carnitine-acylcarnitine translocase (CAC) deficiency is a rare autosomal recessive disorder of long-chain fatty acid oxidation with a severe outcome. We report mutation analysis in a cohort of 12 patients. Twelve mutations were identified of which 9 have not been reported so far (G28C, D32N, R178Q, P230R, D231H, 179delG, 802delG, 69-70insTGTGC, and 609-1g > a). Altogether, including our results, 22 mutations of the CAC gene have been published to date in 23 patients demonstrating the allelic heterogeneity of CAC deficiency. DNA-based prenatal diagnosis was performed for the first time in pregnancies at risk for CAC deficiency. Two fetuses were affected and one pregnancy was terminated by family decision. Two other fetuses had normal genotype and five others were heterozygotes. All the offspring of these seven pregnancies are alive and apparently healthy. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:68 / 73
页数:6
相关论文
共 50 条
  • [1] Carnitine-acylcarnitine translocase deficiency
    Pande, SV
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1999, 318 (01): : 22 - 27
  • [2] Prospective treatment in carnitine-acylcarnitine translocase deficiency
    Pierre, G.
    Macdonald, A.
    Gray, G.
    Hendriksz, C.
    Preece, M. A.
    Chakrapani, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 (05) : 815 - 815
  • [3] CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY AND RECURRENT PANCREATITIS
    Saenz, M. S.
    Van Hove, J. L.
    Gallagher, R.
    Burns, C.
    Thomas, J.
    MOLECULAR GENETICS AND METABOLISM, 2009, 98 (1-2) : 53 - 54
  • [4] Carnitine-acylcarnitine translocase deficiency is a treatable disease
    Al Aqeel, AI
    Rashed, MS
    Wanders, RJA
    JOURNAL OF INHERITED METABOLIC DISEASE, 1999, 22 (03) : 271 - 275
  • [5] Carnitine-acylcarnitine translocase deficiency - a mild phenotype
    Olpin, SE
    Bonham, JR
    Downing, M
    Manning, NJ
    Pollitt, RJ
    Sharrard, MJ
    Tanner, MS
    JOURNAL OF INHERITED METABOLIC DISEASE, 1997, 20 (05) : 714 - 715
  • [6] A patient with carnitine-acylcarnitine translocase deficiency with a mild phenotype
    Morris, AAM
    Olpin, SE
    Brivet, M
    Turnbull, DM
    Jones, RAK
    Leonard, JV
    JOURNAL OF PEDIATRICS, 1998, 132 (03): : 514 - 516
  • [7] Acylcarnitine ratio indices in diagnosing carnitine-acylcarnitine translocase deficiency in newborns
    Tan, Yifei
    Wang, Ling
    Qi, Xiaoying
    Feng, Qingbo
    Luo, Hong
    TRANSLATIONAL PEDIATRICS, 2023, 12 (09) : 1765 - 1766
  • [8] The significance of acylcarnitine ratio indices in diagnosing carnitine-acylcarnitine translocase deficiency
    Shi, Congcong
    Hao, Hu
    Li, Sitao
    TRANSLATIONAL PEDIATRICS, 2023, 12 (09) : 1767 - 1768
  • [9] Carnitine-Acylcarnitine Translocase Deficiency Masked by Extreme Prematurity
    Lund, Kelli C.
    Scottoline, Brian
    Jordan, Brian K.
    JOURNAL OF PEDIATRIC GENETICS, 2023, 12 (02) : 179 - 183
  • [10] CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY - IMPLICATIONS IN HUMAN PATHOLOGY
    PANDE, SV
    MURTHY, MSR
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1994, 1226 (03): : 269 - 276